Late stage 3 chronic kidney disease is an independent risk factor for sarcopenia, but not proteinuriaMost epidemiologic studies assessing the relationship between chronic kidney disease (CKD) and sarcopenia have been performed in dialysis patients. This study aimed to evaluate the relationship between ...
The patients with chronic kidney disease in Thailand has continuously increased and subsequently is the cause of body, mind and social spiritual problems toward patients and created negative economic affect that government has to pay for a great deal of budget in taking care of this group of patie...
Dividing stage 3 of chronic kidney disease (CKD): 3A and 3B Kidney International aims to inform the renal researcher and practicing nephrologists on all aspects of renal research. Clinical and basic renal research, ... GM Kirsztajn,JHR Suassuna,MG Bastos - 《Kidney International》 被引量: 45...
Summary. Background: Venous thromboembolism (VTE) remains a significant complication of major orthopedic surgery, and chronic kidney disease (CKD) is common among elderly patients undergoing total hip replacement (THR). Objectives: The purpose of this study was to evaluate thrombosis and bleeding outco...
271: Characterizing Treatment of Stage 3 Chronic Kidney Disease (CKD) Amongst Hispanics, African-Americans (AA), and Caucasians271: Characterizing Treatment of Stage 3 Chronic Kidney Disease (CKD) Amongst Hispanics, African-Americans (AA), and Caucasiansdoi:10.1053/j.ajkd.2008.02.282None...
Extended-release calcifediol in stage 3–4 chronic kidney disease: a new therapy for the treatment of secondary hyperparathyroidism associated with hypovit... Extended-release calcifediol in stage 3–4 chronic kidney disease: a new therapy for the treatment of secondary hyperparathyroidism associated ...
D iabetes is recognized as one of the biggest global health problems of the 21 century and is the most common cause of chronic kidney disease (CKD) in the elderly. The incidence and prevalence of CKD and end-stage kidney disease (ESKD) increases with age, and results in a considerable so...
Background: Clinical practice guidelines for patients with chronic kidney disease (CKD) recommend regular monitoring and management of kidney function and CKD risk factors. However, the majority of patients with stage 3 CKD lack a diagnosis code, and data on the implementation of these recommendations...
目的 探讨沙库巴曲缬沙坦治疗急性心肌梗死合并Ⅱ~Ⅲ期慢性肾脏病患者住院期间的治疗效果。方法 回顾性分析2019年1月1日至2022年3月31日于安庆市立医院住院的急性心肌梗死合并Ⅱ~Ⅲ期慢性肾脏病患者病历资料,依据其使用不同种类肾素-血管紧张素-醛固酮系统(RAAS)抑制剂将其分组为沙库巴曲缬沙坦组96例,缬沙坦组126例...
Epidemiological studies have shown chronic kidney disease (CKD) to affect 10–12% of the adult population. About half of the patients have moderately reduced renal function (CKD stage 3; eGFR 30–59 ml/min/1.73 m2) [1], [2] and will be treated in primary health care. It is well known...